Zhejiang Huakang Pharmaceutical Co., Ltd. (605077.SS)
CNY 14.79
(-0.47%)
CNY 14.79
(-0.47%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 667.21 Million | 271.97 Million | 264.32 Million | 335.24 Million | 281.3 Million | 140.97 Million |
| Net Income | 371.45 Million | 319.27 Million | 236.7 Million | 307.16 Million | 270.11 Million | 199.37 Million |
| Depreciation & Amortization | 181.52 Million | 106.47 Million | 85.22 Million | 60.08 Million | 51.6 Million | 48.6 Million |
| Deferred income taxes | -1.15 Million | 23.83 Million | -3.17 Million | 19.15 Million | 10.17 Million | 7.14 Million |
| Stock-based compensation | 2.13 Million | - | - | - | - | - |
| Change in working capital | 45.6 Million | -135.88 Million | -31.76 Million | -25.27 Million | -25.31 Million | -99.26 Million |
| Other non-cash items | 387.22 Million | -17.88 Million | -25.84 Million | -6.73 Million | -15.09 Million | -7.74 Million |
| Investing Cash Flow | -1.3 Billion | 63.91 Million | -1.25 Billion | -348.48 Million | -86.33 Million | -116.58 Million |
| Investments in PPE | -690.69 Million | -539.75 Million | -360.92 Million | -252.94 Million | -132.2 Million | -121.37 Million |
| Acquisitions | -527.67 Million | -21 Million | -29.66 Million | 434.76 Thousand | 1.82 Million | - |
| Investment purchases | -20 Million | -421.62 Million | -548.6 Million | -129.2 Million | -164.2 Million | -118.27 Million |
| Sales/Maturities of investments | 20 Million | 505.39 Million | 499.77 Million | 141.38 Million | 195.71 Million | 138.16 Million |
| Other Investing Activities | -87.92 Million | 540.89 Million | -815.52 Million | -108.15 Million | 12.52 Million | -15.1 Million |
| Financing Cash Flow | 1.74 Billion | 391.88 Million | 1.22 Billion | -63.77 Million | -165.29 Million | 62.69 Million |
| Debt repayment | -1.83 Billion | -191.62 Million | -182.04 Million | -156.05 Million | -387.58 Million | -10.18 Million |
| Dividends payments | -137.07 Million | -97.91 Million | -116.56 Million | -52.45 Million | -26.22 Million | -46.49 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 77.36 Million | - | - | - | - | - |
| Other Financing Activities | -36.01 Million | 695.45 Million | 1.52 Billion | 153.1 Million | 275.08 Million | 99 Million |
| Accounts receivables | 14.25 Million | -159.74 Million | -40.49 Million | -28.68 Million | 9.08 Million | -89.29 Million |
| Accounts payables | 51.49 Million | 161.11 Million | 86.9 Million | -6.88 Million | 8.2 Million | 37.91 Million |
| Inventory | -20.13 Million | -161.09 Million | -75 Million | -8.85 Million | -52.78 Million | -55.03 Million |
| Other working capital | -1.00 | 23.83 Million | -3.17 Million | 19.15 Million | 10.17 Million | -44.23 Million |
| Cash at beginning of period | 1.04 Billion | 290.74 Million | 63 Million | 142.3 Million | 110.25 Million | 22.58 Million |
| Cash at end of period | 2.12 Billion | 1.02 Billion | 290.74 Million | 63 Million | 142.3 Million | 110.25 Million |
| Capital Expenditure | -690.69 Million | -539.75 Million | -360.92 Million | -252.94 Million | -132.2 Million | -121.37 Million |
| Effect of forex changes on cash | 862.22 Thousand | 5.02 Million | -1.94 Million | -2.27 Million | 2.36 Million | 592.16 Thousand |
| Net cash flow / Change in cash | 1.08 Billion | 732.79 Million | 227.73 Million | -79.29 Million | 32.04 Million | 87.67 Million |
| Free Cash Flow | -23.47 Million | -267.77 Million | -96.6 Million | 82.29 Million | 149.1 Million | 19.59 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 48.53 Million | 58.38 Million | 79.99 Million | 96.69 Million | 371.45 Million | 89.57 Million |
| Depreciation & Amortization | - | 48.13 Million | 48.13 Million | 46.02 Million | 181.52 Million | -85.05 Million |
| Deferred income taxes | - | - | - | - | -1.15 Million | - |
| Stock-based compensation | - | 9.56 Million | - | 2.13 Million | 2.13 Million | - |
| Change in working capital | - | -284.46 Million | - | -2.88 Million | 45.6 Million | 91.35 Million |
| Other non-cash items | 76.55 Million | 102.87 Million | -208.68 Million | 81.1 Million | 387.22 Million | 70.21 Million |
| Investing Cash Flow | -431.85 Million | -560.98 Million | -400.07 Million | -375.6 Million | -1.3 Billion | -230.25 Million |
| Investments in PPE | -303.06 Million | -427.02 Million | -410.09 Million | -289.66 Million | -690.69 Million | -200.37 Million |
| Acquisitions | 22.68 Thousand | - | -45.03 Million | -45.9 Million | -527.67 Million | 761 Thousand |
| Investment purchases | -17.45 Million | -507.11 Million | - | 6 Million | -20 Million | -13.72 Million |
| Sales/Maturities of investments | 149.8 Million | 428.2 Million | 23.05 Million | -6 Million | 20 Million | -9.27 Million |
| Other Investing Activities | -261.14 Million | -55.05 Million | 55.05 Million | -40.03 Million | -87.92 Million | -7.63 Million |
| Financing Cash Flow | -24.34 Million | -532.9 Million | 110.22 Million | 1.37 Billion | 1.74 Billion | -71.82 Million |
| Debt repayment | -24.43 Million | -359.55 Million | -121.8 Million | -1.3 Billion | -1.83 Billion | -110.7 Million |
| Dividends payments | -7.63 Million | -172.45 Million | -9.82 Million | -137.07 Million | -137.07 Million | -137.07 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | 77.36 Million | 77.36 Million | - |
| Other Financing Activities | 7.72 Million | -170.69 Million | -11.57 Million | 127.64 Million | -36.01 Million | 49.2 Million |
| Accounts receivables | - | -200.19 Million | - | 14.25 Million | 14.25 Million | 53.79 Million |
| Accounts payables | - | - | - | - | 51.49 Million | - |
| Inventory | - | -102.28 Million | - | -20.13 Million | -20.13 Million | 37.56 Million |
| Other working capital | - | 18 Million | - | 3 Million | -1.00 | - |
| Cash at beginning of period | 732.43 Million | 1.71 Billion | 2.12 Billion | 909.16 Million | 1.04 Billion | 1.04 Billion |
| Cash at end of period | 416.21 Million | 739.26 Million | 1.71 Billion | 2.12 Billion | 2.12 Billion | 905.78 Million |
| Capital Expenditure | -303.06 Million | -427.02 Million | -410.09 Million | -289.66 Million | -690.69 Million | -200.37 Million |
| Effect of forex changes on cash | 1.7 Million | 2.86 Million | 1.7 Million | 1.18 Million | 862.22 Thousand | -1.5 Million |
| Net cash flow / Change in cash | -316.22 Million | -976.85 Million | -412.25 Million | 1.21 Billion | 1.08 Billion | -137.49 Million |
| Free Cash Flow | -177.97 Million | -313.89 Million | -538.77 Million | -68.71 Million | -23.47 Million | -34.28 Million |
BRAU
GGIFF
603811
SMFIL
EAWD
600298